Delivery Order SPE2DB22D1106-SPE2DB25FEFS9

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,238.13 firm fixed-price contract is to deliver the medication Cosentyx (secukinumab) 300mg dose-2 pen, which is used to treat certain autoimmune conditions. The contract has a period of performance through September 27, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Cosentyx (Secukinumab) 300 mg pens, a specialty medication used to treat various autoimmune conditions. The contract has a ceiling value of $7,872.80 and runs through April 1, 2025. The contract is a firm fixed-price, delivery order contract and was not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,258.04, is for the delivery of Cosentyx (Secukinumab) 300 mg Dose-2 Pen-Ml, a specialty medication used for the treatment of various conditions. The contract has a firm fixed price pricing type and an ultimate completion date of February 3, 2025. This order is part of a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (Secukinumab) 300mg dose injector pens, a specialty biologic medication used to treat certain autoimmune conditions. The fixed-price contract has a ceiling value of $9,165.29 and a completion date of August 6, 2024. This order is likely part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300mg/2ml medication. The $12,627.76 firm fixed-price contract has an ultimate completion date of November 18, 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab) 300 mg dosage pens, a specialty medication used for various medical conditions. The contract has a ceiling value of $21,495.87 and runs through June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab), a specialty medication used for the treatment of certain autoimmune conditions. The delivery order has a ceiling value of $7,403.51 and a completion date of April 2, 2025. It is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award, valued at $15,236.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx (secukinumab) 150 mg/mL injectable pens, a medication used to treat various autoimmune conditions. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, and has an ultimate completion date of April...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cosentyx (secukinumab) 300 mg/2 mL prefilled pens, a medication used to treat certain autoimmune conditions. The contract has a ceiling value of $1,574.56 and a period of performance through April 23, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx (secukinumab) 300 mg autoinjector pens, a prescription medication used to treat certain autoimmune conditions. The contract has a firm fixed price of $5,137.65 and a period of performance through April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEFS9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,494.92 firm fixed-price contract is for the supply of Cosentyx (secukinumab) 300 mg pens, a biologic medication used to treat various autoimmune conditions. The contract has an ultimate completion date of April 2, 2025 and was awarded on April 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 10:03 AM